Archives of neurology · 2005
Postinfectious myeloradiculoneuropathy with cranial nerve involvements associated with human herpesvirus 7 infection.
Клинический случайСравнительное исследованиеСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mihara Takateru, Mutoh Tatsuro, Yoshikawa Tetsusi, Yano Shigeaki, Asano Yoshizo, Yamamoto Hiroko
Аннотация
BACKGROUND: Infection with human herpesvirus 7 (HHV-7) generally results in a febrile illness with accompanying exanthema subitum.
OBJECTIVES: To ascertain and describe the role of HHV-7 in a case of acute myeloradiculoneuropathy.
PATIENT: A previously healthy young man with complaints of motor weakness, dysphasia, and nasal voice.
METHODS: Serological examinations were performed with the patient's serum. We also examined virus genome DNA in cerebrospinal fluid by regular and real-time polymerase chain reaction. Moreover, we checked the antiganglioside antibody level in the patient's serum samples by the immunoblot analysis.
RESULTS: Serological studies revealed significant change in titers of antibodies against cytomegalovirus, Epstein-Barr virus, and HHV-7, but only HHV-7 genome was detected in the cerebrospinal fluid, with its disappearance after therapy. No antiganglioside antibody was detected in the patient's serum.
CONCLUSION: The unique clinical picture of the present patient might be closely related to the reactivation of HHV-7 in the nervous system.
OBJECTIVES: To ascertain and describe the role of HHV-7 in a case of acute myeloradiculoneuropathy.
PATIENT: A previously healthy young man with complaints of motor weakness, dysphasia, and nasal voice.
METHODS: Serological examinations were performed with the patient's serum. We also examined virus genome DNA in cerebrospinal fluid by regular and real-time polymerase chain reaction. Moreover, we checked the antiganglioside antibody level in the patient's serum samples by the immunoblot analysis.
RESULTS: Serological studies revealed significant change in titers of antibodies against cytomegalovirus, Epstein-Barr virus, and HHV-7, but only HHV-7 genome was detected in the cerebrospinal fluid, with its disappearance after therapy. No antiganglioside antibody was detected in the patient's serum.
CONCLUSION: The unique clinical picture of the present patient might be closely related to the reactivation of HHV-7 in the nervous system.